LRRK2 and GBA Variants Exert Distinct Influences on Parkinson's Disease-Specific Metabolic Networks. (9th December 2019)

• Record Type: Journal Article
• Authors: Schindlbeck, Katharina A; Vo, An; Nguyen, Nha; Tang, Chris C; Niethammer, Martin; Dhawan, Vijay; Brandt, Vicky; Saunders-Pullman, Rachel; Bressman, Susan B; Eidelberg, David
• Is Part Of: Cerebral cortex. Volume 30:Number 5(2020)
• Page Start: 2867
• Page End: 2878
• Publication Date: 2019-12-09
• Subjects: functional connectivity -- GBA -- LRRK2 -- metabolic imaging -- Parkinson's disease; Cerebral cortex -- Periodicals; Brain -- Periodicals; 612.825
• DOI: 10.1093/cercor/bhz280
• Languages: English
• ISSNs: 1047-3211

Abstract

Abstract: The natural history of idiopathic Parkinson's disease (PD) varies considerably across patients. While PD is generally sporadic, there are known genetic influences: the two most common, mutations in the LRRK2 or GBA1 gene, are associated with slower and more aggressive progression, respectively. Here, we applied graph theory to metabolic brain imaging to understand the effects of genotype on the organization of previously established PD-specific networks. We found that closely matched PD patient groups with the LRRK2-G2019S mutation (PD-LRRK2) or GBA1 variants (PD-GBA) expressed the same disease networks as sporadic disease (sPD), but PD-LRRK2 and PD-GBA patients exhibited abnormal increases in network connectivity that were not present in sPD. Using a community detection strategy, we found that the location and modular distribution of these connections differed strikingly across genotypes. In PD-LRRK2, connections were gained within the network core, with the formation of distinct functional pathways linking the cerebellum and putamen. In PD-GBA, by contrast, the majority of functional connections were formed outside the core, involving corticocortical pathways at the network periphery. Strategically localized connections within the core in PD-LRRK2 may maintain PD network activity at lower levels than in PD-GBA, resulting in a less aggressive clinical course.